Cibles Thérapeutiques et conception de médicaments

Cibles Thérapeutiques et conception de médicaments

Open Access statistics for Cibles Thérapeutiques et conception de médicaments, France, covering academic research published from 2000 to 2024.

Open Access statistics for Cibles Thérapeutiques et conception de médicaments, France, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

78%


Total
Publications

92


Total Open
Publications

72


Total
Citations

2.6K


Open Access
Percentage

78%


Total
Publications

92


Total Open
Publications

72


Total
Citations

2.6K

Website

download

Breakdown

16% 44% 17% 23%

Publisher Open

16%

Both

44%

Other Platform Open

17%

Closed

23%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416182022Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

50%OA Journal

OA Journal 50%

26

Hybrid 40%

21

No Guarantees 10%

5

Other Platform Open

Institution 91%

50

Domain 56%

31

Other Internet 11%

6

Preprint 0%

0

Public 0%

0

Other Platform Locations

Name

Platform Type

Publications

Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
51
PubMed Central
Domain
31
DOI
Other Internet
5
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI
Institution
3
Europe PMC
Domain
3
Universite de Bordeaux - Oskar-Bordeaux
Institution
2
4 institutions : Université de Strasbourg, Université de Haute Alsace, INSA Strasbourg, Bibliothèque Nationale et Universitaire de Strasbourg - univOAK
Institution
2
Unknown Repository
Other Internet
1
Università Cattolica del Sacro Cuore - PubliCatt
Institution
1
University of Zaragoza Repository - Zaguan
Institution
1
1 / 2

Data updated 18 August 2025

Share

Share

Share